Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
Mon Compte
No element in selection

Favoris
Établissements de santé
Contact Abonnez-vous aux actualités

1 result

Active substance : sirolimus
Active substance : ivabradine
Type : Drugs, devices and medical acts
Type : Health technology assessment
Topics : Economics and public health
Topics : Protheses and implants

Topic

Economics and public health (1)
Plus ...
- Health economics (1)
Diagnostic and therapeutic techniques (1)
Plus ...
- Protheses and implants (1)
Diseases and conditions (1)
Plus ...
- Heart diseases (1)
- Plus ...
  - Myocardial ischemia (1)

Drugs, devices and medical acts (1)
Plus ...
- Health technology assessment (1)

industriels (1)

Français (1)

Active substance

acide salicylique (1)
aspirine (1)
bivalirudine (1)
chrome (1)
clopidogrel (1)
cobalt (1)
ivabradine (1)
paclitaxel (1)
prasugrel (1)
sirolimus (1)

More filter Other Filter Icon

Other Filter Icon

Search Export

Drugs, devices and medical acts

Première page
Page précédente
/ 1
Page suivante
Dernière page

Sorted by :Date

Relevance
Title

Assessment of drug-eluting stents

Health technology assessment - Posted on 19/02/2010

Download document

Add to my selection

Première page
Page précédente
/ 1
Page suivante
Dernière page
20 par pages

Follow us :

Advancing quality in the fields of health and social care services

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

TrGmCyQSBG23yS91